Company Filing History:
2 out of 28 
2 out of 14 Years Active: 2008-2013
Title: The Innovations of Isabelle Charlebois
Introduction
Isabelle Charlebois is a notable inventor based in St-Nicolas, Canada. She has made significant contributions to the field of biotechnology, particularly in the development of vaccine components for animal health. With a total of four patents to her name, her work has had a meaningful impact on veterinary medicine.
Latest Patents
Among her latest patents, Isabelle has disclosed Group B (GBS) proteins and polynucleotides encoding them. These proteins are antigenic and serve as useful vaccine components for the prophylaxis or therapy of infections in animals. Additionally, she has developed recombinant methods for producing these protein antigens, as well as diagnostic assays for detecting bacterial infections.
Career Highlights
Isabelle has worked with Id Biomedical Corporation and Id Biomedical Corporation of Quebec, where she has applied her expertise in biotechnology. Her innovative approaches have led to advancements in vaccine development and diagnostics.
Collaborations
Isabelle has collaborated with notable professionals in her field, including Bernard R. Brodeur and Denis Martin. These partnerships have further enhanced her research and contributions to biotechnology.
Conclusion
Isabelle Charlebois is a pioneering inventor whose work in vaccine development and diagnostics has made a significant impact in animal health. Her contributions continue to influence the field of biotechnology and improve veterinary practices.